NEW YORK, July 11 - Monday's merger between short interfering RNA therapeutics firms Alnylam and Ribopharma started with friendly discussions between the management at the two companies, but was heavily influenced by venture capitalists' desire to establish a dominant presence in the market.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.